Provided by Tiger Trade Technology Pte. Ltd.

MannKind

4.15
-0.1100-2.58%
Post-market: 4.12-0.0300-0.72%19:30 EDT
Volume:3.20M
Turnover:13.59M
Market Cap:1.33B
PE:-29.64
High:4.36
Open:4.28
Low:4.11
Close:4.26
52wk High:6.51
52wk Low:2.23
Shares:321.54M
Float Shares:309.97M
Volume Ratio:0.82
T/O Rate:1.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1400
EPS(LYR):0.0200
ROE:32.74%
ROA:0.79%
PB:-19.86
PE(LYR):207.50

Loading ...

BRIEF-MannKind Q1 Pretax Profit USD -16.366 Million

Reuters
·
May 07

MannKind Q1 Basic EPS USD -0.05

THOMSON REUTERS
·
May 07

MannKind Reports First Quarter 2026 Financial Results and Provides Business Update

GlobeNewswire
·
May 07

MannKind Buy Rating Reiterated as United Therapeutics Expands DPI Partnership; $8 Price Target Unchanged

TIPRANKS
·
May 07

MannKind Up Over 39%, on Pace for Largest Percent Increase Since September 2018 -- Data Talk

Dow Jones
·
May 06

BUZZ-U.S. STOCKS ON THE MOVE-Walt Disney, CVS, Uber

Reuters
·
May 06

BUZZ-U.S. STOCKS ON THE MOVE-AMD, Apollo, Deckers Outdoor

Reuters
·
May 06

BUZZ-MannKind rises as it partners with United Therapeutics on inhaled drug for rare lung disease

Reuters
·
May 06

MannKind Corp - Eligible for up to $35 Mln in Milestones and 10% Royalties on Net Sales

THOMSON REUTERS
·
May 06

MannKind Corp - Announces Development of Ralinepag Dry Powder Inhalation for United Therapeutics

THOMSON REUTERS
·
May 06

MannKind Announces Ralinepag Dry Powder Inhalation (DPI) Program to be Pursued for Pulmonary Hypertension and Fibrotic Lung Diseases

GlobeNewswire
·
May 06

MannKind to report first-quarter results, host webcast after market close

Reuters
·
Apr 30

MannKind to Report First Quarter 2026 Financial Results on May 6, 2026

GlobeNewswire
·
Apr 30

MannKind Is Maintained at Overweight by Wells Fargo

Dow Jones
·
Apr 28

Analysts’ Opinions Are Mixed on These Healthcare Stocks: United Therapeutics (UTHR), Insmed (INSM) and MannKind (MNKD)

TIPRANKS
·
Apr 28

MannKind’s Inhaled Nintedanib Trial: Early IPF Study Moves Forward

TIPRANKS
·
Apr 17

MannKind price target lowered to $8 from $10 at Mizuho

TIPRANKS
·
Apr 13

MannKind price target lowered to $6 from $7 at Truist

TIPRANKS
·
Apr 08

MannKind announces annual shareholder meeting to be held online

Reuters
·
Apr 08

Analysts Offer Insights on Healthcare Companies: MannKind (MNKD) and Praxis Precision Medicines (PRAX)

TIPRANKS
·
Mar 31